cinnamide-based NMDA antagonists (CoCensys)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecinnamide-based NMDA antagonists (CoCensys)
Drug Alias Namecinnamide-based NMDA antagonists (Oregon/CoCensys)NMDA antagonists (University of Oregon/CoCensys)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oregon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue Pharma IncUniversity Of Oregon
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A